SNTI — Senti Biosciences Balance Sheet
0.000.00%
Last trade - 00:00
- $11.16m
- -$12.46m
- $2.56m
- 19
- 36
- 20
- 14
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 17.8 | 30.5 | 56 | 98.6 | 35.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.078 | 0.317 | 0.483 | 0.626 | 17.7 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 18.8 | 31.7 | 60.2 | 103 | 71.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 16.6 | 16.1 | 33.1 | 74.6 | 41.6 |
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 35.8 | 48.3 | 96.7 | 181 | 119 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.31 | 4.87 | 14.5 | 18.1 | 12.7 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 17.9 | 17.4 | 36.3 | 53.5 | 52.6 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 18 | 30.9 | 60.4 | 127 | 66.9 |
Total Liabilities & Shareholders' Equity | 35.8 | 48.3 | 96.7 | 181 | 119 |
Total Common Shares Outstanding |